In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROSĀ® testing platform to perform COVID-1...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...